OJ
Publicaties op Oncologisch.com
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, pha...
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Gevorderd or Metastatic Non-Small Cell Lung Cancer: Th...
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemoth...
Sacituzumab govitecan versus docetaxel bij eerder behandeld NSCLC: EVOKE-01 fase III
Nivolumab plus ipilimumab plus twee cycli chemotherapie bij NSCLC: CheckMate 9LA fase III